1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CCNF CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA ZNF554 CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA CCDC74B CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA XKR7 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA FLVCR1 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA BRD1 CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA EWSR1 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA ACTL6B CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA MFSD13A CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA RPAIN CTRPv2 pan-cancer AAC 0.15 4e-06
Download CSV